Diabetic Macular Edema in Diabetic Retinopathy (DME)
TOPADUR has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases as chronic wounds, glaucoma, colorectal cancer, hair loss and skin aging.
Topadur has invented and pioneered dual mode of action low molecular weight drugs, which increase microcirculation and capillary perfusion. The unique mode of mechanism translates into a so far unsurpassed potency and efficacy, which enables therapies for several high medical need indications.
